Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Fireworks likely at Senate drug pricing hearing today

Fireworks likely at Senate drug pricing hearing today 15:15 UK time, 16:15 in Europe) and will see the CEOs from AbbVie, AstraZeneca, Bristol-Myers Squibb, Merck &Co, Pfizer, and Sanofi (plus the head of J&J's

Innovent gears up for PD-1 inhibitor launch in China

Innovent gears up for PD-1 inhibitor launch in China The home-grown PD-1 inhibitors join Bristol-Myers Squibb and Merck &Co/MSD’s rival drugs on the Chinese market.

More good news, and some bad, for Merck’s Keytruda

More good news, and some bad, for Merck’s Keytruda The rare setback for Keytruda comes as it has started to show signs of lengthening its new lead in the PD1/PD-L1 inhibitor category over main rival Bristol-Myers Squibb

2019: CRISPR and therapeutic gene editing comes of age

2019: CRISPR and therapeutic gene editing comes of age The cells were gene-edited to lack PD-1, the immune checkpoint targeted by drugs such as Merck &Co’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo (nivolumab), and the

Merck puts prostate cancer firmly in Keytruda’s sights

Merck puts prostate cancer firmly in Keytruda’s sights Merck has competition in this area of course, and arch-rival in the cancer immunotherapy category, Bristol Myers Squibb, reported results at ASCO GU with its double immunotherapy combination of

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics